Allergy Partners of Western NC

Asheville, North Carolina 28801

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Urticaria

Studies at this site

• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed
• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) — Completed
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed